menu
    • menu
    [{"orgOrder":0,"company":"Ascentage Pharma","sponsor":"J.P. Morgan","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"CHINA","productType":"Other Small Molecule","year":"2025","type":"Private Placement","leadProduct":"Olverembatinib","moa":"||BCR-ABL","graph1":"Oncology","graph2":"Approved FDF","graph3":"Ascentage Pharma","amount2":0.19,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Oncology","amount2New":0.19,"dosageForm":"Oral Tablet","sponsorNew":"Ascentage Pharma \/ J.P. Morgan","highestDevelopmentStatusID":"15","companyTruncated":"Ascentage Pharma \/ J.P. Morgan"}]

    Find Clinical Drug Pipeline Developments & Deals for Bosutinib

    Menu

    Bosutinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Ascentage Pharma

                            China arrow
                            AGGSpend
                            Not Confirmed

                            Ascentage Pharma

                            China arrow
                            AGGSpend
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Olverembatinib,Bosutinib

                            Therapeutic Area : Oncology

                            Study Phase : Phase III

                            Sponsor : J.P. Morgan

                            Deal Size : $190.1 million

                            Deal Type : Private Placement

                            DEALS_DEV arrow-down

                            Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement

                            Details : The proceeds from the placement will be used to advance the late-stage product HQP1351 (Olverembatinib), which is being evaluated for the treatment of Chronic Myeloid Leukemia.

                            Product Name : HQP1351

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            July 17, 2025

                            Lead Product(s) : Olverembatinib,Bosutinib

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase III

                            Sponsor : J.P. Morgan

                            Deal Size : $190.1 million

                            Deal Type : Private Placement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth